Clinical trial
Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease
NCT04956939 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease
- Lead sponsor
- Rush University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 17, 2018
- Completion date
- March 31, 2021
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.